| Source: |
| Type: |
| Myeloid-derived suppressor cells (MDSCs) are a type of immune cell that plays a significant role in cancer progression and immune evasion. They are a heterogeneous group of cells that are characterized by their ability to suppress the immune response, particularly the activity of T cells. MDSCs are typically found in the tumor microenvironment and are thought to be recruited to the tumor site by various factors, including tumor-derived cytokines and chemokines. Once at the tumor site, MDSCs can suppress the immune response in several ways, including: -Inhibiting the activation and proliferation of T cells. -Suppressing the production of cytokines and chemokines that are necessary for an effective immune response. -Inducing the production of anti-inflammatory cytokines that promote tumor growth and survival. -Inhibiting the activity of natural killer (NK) cells and other immune cells that are important for tumor surveillance. |
| Lung CSC (Cancer Stem Cells) markers (CD133, CD44, ALDHA1, Nanog and Oct4) |
| 428- | Chit, | docx, | CUR, | Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer |
| - | vitro+vivo, | Lung, | H460 | - | vitro+vivo, | Lung, | H1299 | - | vitro+vivo, | Lung, | A549 | - | vitro+vivo, | Lung, | PC9 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:15 Cells:% prod#:% Target#:672 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid